On-Demand · February 19, 2026

The Science of Alcohol Intoxication: Navigating Dram Shop and Liquor Liability

Master alcohol toxicology and dram shop liability. Gain expert-backed skills to interpret toxicology results, collaborate with witnesses, and win alcohol-related cases

David M. Lehmann Intertox IncHeidi C. O’Neill, PhD, DABT Intertox IncMichael J. Laszlo Clark Hill PLCPatrick Maroney Maroney Consulting Services LLC

About this program

Course Overview

Mastering Alcohol Toxicology for Dram Shop Litigation

Attorneys will learn alcohol toxicology science, dram shop liability, and how to work effectively with expert witnesses in alcohol-related civil and criminal cases.

  • Alcohol toxicology Interpret how the body absorbs and eliminates alcohol.
  • Body impairment Identify alcohol's pharmacodynamic effects on human behavior.
  • Dram shop Apply liability principles to alcohol-related cases.
  • Expert collaboration Gather toxicologist-required information to strengthen client representation.

Why Attend

Understanding alcohol toxicology and dram shop liability is essential for civil attorneys navigating complex causation disputes where scientific evidence directly determines client outcomes.

  • 43+ States have active dram shop laws as of 2025, meaning alcohol-serving establishments face civil liability exposure in nearly every U.S. jurisdiction where a patron causes injury after being over-served.
  • 12k People died in alcohol-impaired driving crashes in the last couple of years, with each fatality representing a potential wrongful death or personal injury civil claim — and a possible dram shop defendant beyond just the intoxicated driver.
  • $373B Is the inflation-adjusted 2025 estimated comprehensive cost of drunk driving crashes above the legal BAC limit, reflecting the enormous damages pool at stake in alcohol-related civil litigation nationwide.
  • $1.77 Was paid out by insurers for every $1.00 of liquor liability premium collected between 2017 and 2022, making the market deeply unprofitable and driving significant rate increases in 2024 — directly affecting the insurance coverage landscape civil attorneys must evaluate in every dram shop case.

Key Topics

  • Alcohol Toxicology A foundational review of alcohol toxicology principles.
  • Pharmacokinetics What the body does to alcohol.
  • Pharmacodynamics What alcohol does to the body
  • Dram shop Analysis of dram shop liability for alcohol-related legal matters.
  • Toxicologist role Information toxicologists need from attorneys to analyze alcohol-related cases.
  • Case collaboration How attorneys can better collaborate with experts for stronger representation.

What You Will Learn and Gain

What you will learn

Attorneys will learn the science of alcohol's behavior in the human body, covering both pharmacokinetics and pharmacodynamics.

What you will gain

Attorneys will gain the ability to interpret toxicology results effectively and understand how dram shop laws apply in civil and criminal cases.

Speakers

David M. Lehmann

David M. Lehmann

Intertox Inc

David M. Lehmann, Ph.D., is a distinguished toxicologist with nearly two decades of multidisciplinary experience spanning academia, industry, and government. As a Senior Toxicologist at Intertox, Inc., he specializes in evaluating human health risks associated with environmental pollutants, alcohol and drugs, medical devices, and consumer products. Equally accomplished as a laboratory scientist and a written communicator, Dr. Lehmann brings a rare combination of investigational rigor and analytical clarity to every engagement — making him a trusted resource for clients navigating complex regulatory, litigation, and public health challenges.

Full profile

Experience

Dr. Lehmann joined Intertox, Inc. in 2025, bringing with him a career built on scientific excellence across research, regulatory science, and applied consulting. His investigational expertise spans a broad range of toxicological endpoints, including respiratory and contact hypersensitivity reactions, immunosuppression, hematology, skin and eye irritation, cytotoxicity, genotoxicity, and the effects of insecticides on pollinator health. In the area of human health risk assessment, he applies weight-of-evidence frameworks — including the Bradford Hill criteria — to causation analyses involving pesticides, metals, medical devices, and other chemical agents, delivering defensible and regulatory-ready evaluations. His background in pharmacology and cellular mechanisms further supports both clinical and non-clinical risk assessments involving drug-related signal transduction pathways. Dr. Lehmann is also experienced in designing, conducting, and interpreting in vivo and in vitro toxicology studies built to satisfy regulatory requirements, and he is skilled in systematic review and evidence mapping — conducting comprehensive literature searches and producing the evidence maps that underpin robust risk assessments. Throughout his career, Dr. Lehmann has consistently demonstrated an exceptional ability to address multifaceted scientific questions with precision, clarity, and a proven commitment to serving client needs.

Education

Dr. Lehmann earned his Bachelor of Science in Biology from Colorado State University before pursuing advanced training at the University of Rochester School of Medicine and Dentistry, where he completed both his Master of Science and Doctor of Philosophy in Toxicology. He subsequently completed a PostDoctoral Appointment in Pharmacology, also at the University of Rochester School of Medicine and Dentistry, further deepening his expertise in drug-related mechanisms and human physiological responses.

Recognition

Dr. Lehmann is internationally recognized for his contributions to the development and validation of new approach methodologies (NAMs) and non-animal testing methods. He has been selected as a contributor to ICCVAM, the Interagency Coordinating Committee on the Validation of Alternative Methods, and has served as an expert panel member for OECD working groups charged with developing new toxicological test guidelines across critical endpoints — including skin sensitization, respiratory sensitization, immunotoxicology, and skin and eye irritation. His appointment to international peer review panels for non-animal toxicity testing methods reflects the scientific community's confidence in his expertise and judgment, and his work in this space continues to shape the future of regulatory toxicology on a global scale.

Professional involvement

Beyond his client-facing work, Dr. Lehmann is an engaged and active contributor to the broader scientific community. Through his ongoing roles with ICCVAM and OECD expert groups, he participates in federal interagency and international initiatives aimed at advancing the validation and regulatory acceptance of alternative test methods. He also serves as a peer reviewer for international toxicity testing methodologies and validation programs. A committed educator and communicator, Dr. Lehmann is recognized for his ability to translate complex toxicological science for a wide range of audiences — from undergraduate and graduate students to industry professionals, policymakers, and community stakeholders.
Heidy O’Neil

Heidy O’Neil

Intertox Inc

Heidi C. O’Neill, Ph.D., DABT, is a highly accomplished toxicologist with more than two decades of experience investigating the effects of chemical compounds on human health — both as pharmacological therapeutics with the potential to benefit and as toxicants with the potential to harm. As a Senior Toxicologist at Intertox, Inc., Dr. O’Neill brings deep expertise in human health risk assessment for consumer products, industrial chemicals, and regulated substances, with a particular focus on flavoring compounds, solvents, organophosphates, pesticides, and extractable and leachable chemicals. Her career reflects an exceptional ability to translate complex toxicological science into practical, defensible guidance for regulatory, litigation, and industry audiences alike.

Full profile

Experience

Dr. O'Neill joined Intertox, Inc. in 2024, bringing with her more than twenty years of experience at the intersection of toxicology, regulatory science, and applied risk assessment. Her practice spans human health risk assessment for a diverse portfolio of consumer products — including tobacco products, cannabis vape products, food, and personal care products — as well as toxicological evaluations in industrial and pharmaceutical settings. She has particular expertise in evaluating the health risks posed by f lavoring compounds in oral, food, and inhalation products, and in assessing solvents, organophosphates, and pesticides for their potential impacts on human health. Dr. O'Neill has extensive experience preparing FDA submissions for consumer products, with a specialized focus on both inhaled and oral nicotine products, and she is well-versed in the regulatory landscape governing these categories. She also conducts toxicological evaluations to support extractable and leachable chemical assessments and performs product stewardship reviews for a wide range of chemical compounds. Rounding out her practice, Dr. O'Neill provides expert scientific support in litigation matters, offering well-reasoned, evidence-based toxicological analyses that serve the needs of legal teams and their clients.

Education

Dr. O'Neill earned her Bachelor of Science in Psychology from the University of Colorado, Denver, before pursuing advanced scientific training at the University of Colorado School of Medicine, where she completed her Doctor of Philosophy in Toxicology. She holds board certification as a Diplomate of the American Board of Toxicology (DABT), a prestigious credential that recognizes demonstrated competency and professional excellence in the science of toxicology.

Recognition

Dr. O'Neill's board certification as a Diplomate of the American Board of Toxicology reflects the professional community's recognition of her expertise and commitment to the highest standards of scientific practice. Over the course of her career, she has taken on increasingly complex roles in human health risk assessment, regulatory science, and litigation support — establishing herself as a sought-after expert across both consumer product and industrial settings. Notably, she has contributed to the development of innovative internal safety systems, including laying the groundwork for a Safety Data Sheet (SDS) screening framework designed to build a comprehensive database supporting go/no-go decisions for worker safety at a major food company.

Professional involvement

Dr. O'Neill is an engaged member of the toxicology and regulatory science communities. Her professional work encompasses collaboration with industry stakeholders, regulatory bodies, and legal teams across a wide range of disciplines. She has played an active role in supporting FDA regulatory submissions for tobacco products — both oral and inhaled — and has contributed expert toxicological analyses in support of legal proceedings. Her breadth of involvement across consumer product safety, pharmaceutical product assessment, and occupational health reflects a career defined by interdisciplinary engagement and a consistent commitment to advancing science-based decision making.
Michael J. Laszlo

Michael J. Laszlo

Clark Hill PLC

Mike Laszlo is an accomplished litigator and business counselor who focuses his practice on the food, beverage, and hospitality industries, representing restaurant groups, wineries, distilleries, breweries, importers, wholesalers, and retailers.

Full profile

Experience

Represents businesses in all aspects of the food, beverage, and hospitality industry including corporate and commercial matters, litigation, complex liquor licensing and three-tier issues, and alcohol franchise laws. Extensive experience at all stages of litigation including trials and appeals. Has served in business roles over the years. Advises startups and industry juggernauts on corporate and commercial transactions, trademarks, and complex business matters.

Recognition

Frequent speaker and commentator on alcohol beverage law and business and commercial law.

Professional involvement

Extensive experience in alternative dispute resolution including mediation and arbitration.
Patrick Maroney

Patrick Maroney

Maroney Consulting Services LLC

Patrick Maroney is the President of Maroney Consulting Services LLC, providing consulting related to liquor laws, rules, liability, training and compliance for liquor licenses and stakeholders with over 33 years of experience in law enforcement and regulatory compliance.

Full profile

Experience

Over 33 years of experience in law enforcement and regulatory compliance. Retired from the state of Colorado in June 2019 where he served as Director for the Colorado Liquor Enforcement Division (LED) since 2013. Previously served as Chief of Investigations for LED for over two years. Worked for Colorado Lottery, Colorado Bureau of Investigation, Arapahoe County Coroner's Office, and Larimer County Sheriff's Office. Worked closely with liquor stakeholders in 2016 and 2018 to implement two bills that brought significant changes to Colorado's liquor laws.

Professional involvement

Former board member of the National Conference of State Liquor Administrators (NCSLA). Served on several panels during NCSLA conferences and hosted the 2017 National Conference in Denver.

Agenda

  1. SESSION 1 · 1:00 pm - 1:20 pm

    Review of Alcohol Toxicology

    Build a foundational understanding of alcohol toxicology, including key scientific principles and terminology that attorneys need to effectively evaluate intoxication evidence and expert testimony in alcohol-related civil and criminal cases.

    David M. Lehmann, Heidy O’Neil, Michael J. Laszlo, Patrick Maroney

  2. SESSION 2 · 1:20 pm - 1:40 pm

    What The Body Does to Alcohol

    Examine how the body absorbs, distributes, and eliminates alcohol, and how these pharmacokinetic processes directly impact BAC calculations, timeline reconstruction, and the liability arguments attorneys must address in alcohol-related civil litigation.

    David M. Lehmann, Heidy O’Neil, Michael J. Laszlo, Patrick Maroney

  3. SESSION 3 · 1:40 pm - 2:00 pm

    What Alcohol Does to the Body

    Explore alcohol’s pharmacodynamic effects on human physiology and behavior, giving attorneys the scientific foundation they need to evaluate impairment claims, challenge opposing experts, and build stronger representation in alcohol-related cases.

    David M. Lehmann, Heidy O’Neil, Michael J. Laszlo, Patrick Maroney

  4. SESSION 4 · 2:10 pm - 2:30 pm

    Dram Shop Liability

    Analyze how civil liability attaches to alcohol-serving establishments under dram shop laws and learn how these statutes apply across both plaintiff and defense strategies in personal injury and wrongful death litigation.

    David M. Lehmann, Heidy O’Neil, Michael J. Laszlo, Patrick Maroney

  5. SESSION 5 · 2:30 pm - 2:50 pm

    The Role of Toxicologists in Alcohol-Related Legal Cases

    Discover what critical information toxicologists need from attorneys and learn how to effectively collaborate with expert witnesses to interpret complex scientific findings and build stronger arguments in alcohol-related legal cases today.

    David M. Lehmann, Heidy O’Neil, Michael J. Laszlo, Patrick Maroney

  6. Session 6 · 2:50 pm - 3:10 pm

    Key Takeaways and Practitioner Q&A Session

    Review essential principles including state-specific dram shop requirements, the distinction between visible intoxication and consumption amounts, and the critical role of experts. Engage in Q&A to address specific practitioner questions and case scenarios.

    David M. Lehmann, Heidy O’Neil, Michael J. Laszlo, Patrick Maroney

MCLE Credits

  • Alabama

    Approved for Self-Study Credits

    2 General

  • Alaska

    Approved for CLE Credits

    2 General

    Our programs are CLE-eligible through Alaska’s recognition of multi-jurisdictional reciprocity.

  • Arizona

    Approved for CLE Credits

    2 General

  • Arkansas

    Approved for CLE Credits

    2 General

  • California

    Approved for CLE Credits

    2 General

  • Colorado

    Pending CLE Approval

    2 General

  • Connecticut

    Approved for CLE Credits

    2 General

  • Delaware

    Pending CLE Approval

    2 General

  • District of Columbia

    No MCLE Required

    No MCLE Required

  • Florida

    Pending CLE Approval

    2 General Hours

    Receive CLE credit in Florida via Attorney Submission.

  • Georgia

    Approved for CLE Credits

    2 General

  • Hawaii

    Approved for CLE Credits

    2 General

  • Idaho

    Pending CLE Approval

    2 General

  • Illinois

    Approved for Self-Study Credits

    2 General

  • Indiana

    Approved For On-Demand Credits

    2 General

  • Iowa

    Pending CLE Approval

    2 General

  • Kansas

    Pending CLE Approval

    2 Substantive

  • Kentucky

    Pending CLE Approval

    2 General

  • Louisiana

    Pending CLE Approval

    2 General

  • Maine

    Pending CLE Approval

    2 General

  • Maryland

    No MCLE Required

    2 CLE Hour(s)

  • Massachusetts

    No MCLE Required

    2 CLE Hour(s)

  • Michigan

    No MCLE Required

    2 CLE Hour(s)

  • Minnesota

    Approved for Self-Study Credits

    2 General

  • Mississippi

    Pending CLE Approval

    2 General

  • Missouri

    Approved for Self-Study Credits

    2.4 General

  • Montana

    Pending CLE Approval

    2 General

  • Nebraska

    Pending CLE Approval

    2 General

    myLawCLE reports attendance to Nebraska on each attorney’s behalf for all programs. Please do not self-report.

  • Nevada

    Approved for Self-Study Credits

    2 General

  • New Hampshire

    Approved for CLE Credits

    120 General minutes

    As of July 1, 2014, the NHMCLE Board no longer provides pre- or post-approval of courses. Attendees must self-determine whether a program is eligible for credit, and self-report their attendance online at www.nhbar.org, based on qualification provisions of Rule 53.

  • New Jersey

    Approved for CLE Credits

    2 General

    Our programs are CLE-eligible through New Jersey’s recognition of multi-jurisdictional reciprocity, except for the courses required under BCLE Reg. 201:2

  • New Mexico

    Approved for Self-Study Credits

    2 General

  • New York

    Approved for CLE Credits

    2 General

    Our programs are CLE-eligible through New York’s Approved Jurisdiction Group “B”.

  • North Carolina

    Pending CLE Approval

    2 General

  • North Dakota

    Approved for CLE Credits

    2 General

    Our programs are CLE-eligible through North Dakota’s recognition of multi-jurisdictional reciprocity. Section 1, Policy 1.14

  • Ohio

    Approved for Self-Study Credits

    2 General

  • Oklahoma

    Approved for Self-Study Credits

    2.5 General

  • Oregon

    Approved for Self-Study Credits

    2 General

  • Pennsylvania

    Approved for Self-Study Credits

    2 General

  • Rhode Island

    Pending CLE Approval

    2.5 General

  • South Carolina

    Pending CLE Approval

    2 General

  • South Dakota

    No MCLE Required

    2 CLE Hour(s)

  • Tennessee

    Approved for Self-Study Credits

    2 General

  • Texas

    Approved for CLE Credits

    2 General

  • Utah

    Pending CLE Approval

    2 General

  • Vermont

    Approved for CLE Credits

    2 General

  • Virginia

    Not Eligible

    2 General Hours

  • Washington

    Approved for Self-Study Credits

    2 Law & Legal Hours

  • West Virginia

    Pending CLE Approval

    2.4 General

  • Wisconsin

    Approved for Self-Study Credits

    2 General

  • Wyoming

    Approved for Self-Study Credits

    2 General